Literature DB >> 20386057

Designing studies that would address the multilayered nature of health care.

David M Murray1, Michael Pennell, Dale Rhoda, Erinn M Hade, Electra D Paskett.   

Abstract

We review design and analytic methods available for multilevel interventions in cancer research with particular attention to study design, sample size requirements, and potential to provide statistical evidence for causal inference. The most appropriate methods will depend on the stage of development of the research and whether randomization is possible. Early on, fractional factorial designs may be used to screen intervention components, particularly when randomization of individuals is possible. Quasi-experimental designs, including time-series and multiple baseline designs, can be useful once the intervention is designed because they require few sites and can provide the preliminary evidence to plan efficacy studies. In efficacy and effectiveness studies, group-randomized trials are preferred when randomization is possible and regression discontinuity designs are preferred otherwise if assignment based on a quantitative score is possible. Quasi-experimental designs may be used, especially when combined with recent developments in analytic methods to reduce bias in effect estimates.

Entities:  

Mesh:

Year:  2010        PMID: 20386057      PMCID: PMC3482955          DOI: 10.1093/jncimonographs/lgq014

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN: 1052-6773


  37 in total

1.  A Monte Carlo study of alternative responses to intraclass correlation in community trials. Is it ever possible to avoid Cornfield's penalties?

Authors:  D M Murray; P J Hannan; W L Baker
Journal:  Eval Rev       Date:  1996-06

Review 2.  Design and analysis of group-randomized trials: a review of recent methodological developments.

Authors:  David M Murray; Sherri P Varnell; Jonathan L Blitstein
Journal:  Am J Public Health       Date:  2004-03       Impact factor: 9.308

3.  The search for evidence of effective health promotion.

Authors:  V Speller; A Learmonth; D Harrison
Journal:  BMJ       Date:  1997-08-09

Review 4.  Efficacy and effectiveness trials (and other phases of research) in the development of health promotion programs.

Authors:  B R Flay
Journal:  Prev Med       Date:  1986-09       Impact factor: 4.018

5.  Community-based interventions to improve breast and cervical cancer screening: results of the Forsyth County Cancer Screening (FoCaS) Project.

Authors:  E D Paskett; C M Tatum; R D'Agostino; J Rushing; R Velez; R Michielutte; M Dignan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-05       Impact factor: 4.254

6.  The scientific approach to cancer control.

Authors:  P Greenwald; J W Cullen
Journal:  CA Cancer J Clin       Date:  1984 Nov-Dec       Impact factor: 508.702

7.  Making the system work. Training pediatric oncology patients to cope and their parents to coach them during BMA/LP procedures.

Authors:  R L Blount; S W Powers; M W Cotter; S Swan; K Free
Journal:  Behav Modif       Date:  1994-01

8.  Effectiveness of implementing the agency for healthcare research and quality smoking cessation clinical practice guideline: a randomized, controlled trial.

Authors:  David A Katz; Donna R Muehlenbruch; Roger L Brown; Michael C Fiore; Timothy B Baker
Journal:  J Natl Cancer Inst       Date:  2004-04-21       Impact factor: 13.506

9.  Cutoff assignment strategies for enhancing randomized clinical trials.

Authors:  W M Trochim; J C Cappelleri
Journal:  Control Clin Trials       Date:  1992-06

10.  Using intervention time series analyses to assess the effects of imperfectly identifiable natural events: a general method and example.

Authors:  Stuart Gilmour; Louisa Degenhardt; Wayne Hall; Carolyn Day
Journal:  BMC Med Res Methodol       Date:  2006-04-03       Impact factor: 4.615

View more
  17 in total

Review 1.  Multilevel interventions and racial/ethnic health disparities.

Authors:  Sherri Sheinfeld Gorin; Hoda Badr; Paul Krebs; Irene Prabhu Das
Journal:  J Natl Cancer Inst Monogr       Date:  2012-05

2.  Foreword.

Authors:  Rachel Ballard-Barbash
Journal:  J Natl Cancer Inst Monogr       Date:  2010

Review 3.  Toward improving the quality of cancer care: addressing the interfaces of primary and oncology-related subspecialty care.

Authors:  Stephen Hunt Taplin; Anne Brown Rodgers
Journal:  J Natl Cancer Inst Monogr       Date:  2010

Review 4.  Interfaces across the cancer continuum offer opportunities to improve the process of care.

Authors:  Stephen H Taplin; Steve Clauser; Anne B Rodgers; Erica Breslau; Daniel Rayson
Journal:  J Natl Cancer Inst Monogr       Date:  2010

Review 5.  Review of Recent Methodological Developments in Group-Randomized Trials: Part 1-Design.

Authors:  Elizabeth L Turner; Fan Li; John A Gallis; Melanie Prague; David M Murray
Journal:  Am J Public Health       Date:  2017-04-20       Impact factor: 9.308

6.  The Importance of Evaluating Health Disparities Research.

Authors:  Bruce A Dye; Deborah G Duran; David M Murray; John W Creswell; Patrick Richard; Tilda Farhat; Nancy Breen; Michael M Engelgau
Journal:  Am J Public Health       Date:  2019-01       Impact factor: 9.308

7.  Evidence from regression-discontinuity analyses for beneficial effects of a criterion-based increase in alcohol treatment.

Authors:  Rosely Flam-Zalcman; Robert E Mann; Gina Stoduto; Thomas H Nochajski; Brian R Rush; Anja Koski-Jännes; Christine M Wickens; Rita K Thomas; Jürgen Rehm
Journal:  Int J Methods Psychiatr Res       Date:  2012-11-20       Impact factor: 4.035

8.  Developing a research agenda for cardiovascular disease prevention in high-risk rural communities.

Authors:  Cathy L Melvin; Giselle Corbie-Smith; Shiriki K Kumanyika; Charlotte A Pratt; Cheryl Nelson; Evelyn R Walker; Alice Ammerman; Guadalupe X Ayala; Lyle G Best; Andrea L Cherrington; Christina D Economos; Lawrence W Green; Jane Harman; Steven P Hooker; David M Murray; Michael G Perri; Thomas C Ricketts
Journal:  Am J Public Health       Date:  2013-04-18       Impact factor: 9.308

Review 9.  Measuring improvement in populations: implementing and evaluating successful change in lung cancer care.

Authors:  Xinhua Yu; Lisa M Klesges; Mathew P Smeltzer; Raymond U Osarogiagbon
Journal:  Transl Lung Cancer Res       Date:  2015-08

Review 10.  Design and analysis of group-randomized trials in cancer: A review of current practices.

Authors:  David M Murray; Sherri L Pals; Stephanie M George; Andrey Kuzmichev; Gabriel Y Lai; Jocelyn A Lee; Ranell L Myles; Shakira M Nelson
Journal:  Prev Med       Date:  2018-03-16       Impact factor: 4.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.